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ABSTRACT
Background and Objectives: The purpose of this study
was to assess the long-term efficacy of laparoscopic laser
surgery in the treatment of painful pelvic endometriosis.
Methods: We  conducted a long-term follow-up of 56
patients who had participated in a randomized, double-
blind controlled study at a tertiary referral center for the
laparoscopic treatment of endometriosis. The patients
had pelvic pain, minimal-to-moderate endometriosis, and
underwent laser laparoscopy. We asked patients whether
they had now achieved satisfactory symptom relief or
whether they had received any further medical interven-
tion for their endometriosis. The main outcome measure
was continued symptom relief after treatment and subse-
quent medical history.
Results: Of the original 56 patients, we were able to
contact 38 (67.9%). The mean (range) time since opera-
tion was 73 months. Painful symptoms had recurred in
28/38 (73.7%) patients at some point since their opera-
tion. The median (range) time for recurrence was 19.7 (5-
60) months. At the time of follow-up, satisfactory symp-
tom relief was reported in 21/38 (55.3%) patients. The
remaining 17/38 (44.7%) patients continued to experi-
ence painful symptoms, and eight eventually had a hys-
terectomy.
Conclusions: This study suggests that operative
laparoscopy can have long-term benefits for the majority
of women with pelvic pain due to endometriosis, but
because of the small numbers, this study lacks the power
to demonstrate this conclusively. 
Key Words: Endometriosis, Pelvic pain, Long-term fol-
low-up, Laser laparoscopy.
INTRODUCTION
In 1994, the results of the first and only double-blind ran-
domized controlled trial1 to assess pain relief following
laparoscopic laser ablation of endometriosis stages I – III
(r-AFS classification)2 was published. The purpose of our
report is to describe the long-term (> 6 years) follow-up
data on the patients in the original study who underwent
laser laparoscopy. 
Endometriosis is a common and debilitating disorder that
diminishes the quality of women’s lives in their repro-
ductive years. Women with endometriosis are initially
referred to the gynecologist because of pelvic pain that
is often associated with subfertility. The long-term effects
of this condition have profound consequences for the
sexual, social, and professional aspects of their lives. 
In studies where endometriosis remains untreated for up
to 12 months, the disease progresses or remains static in
approximately two thirds of women.3-6 Therefore, the
long-term effectiveness of therapy is of enormous impor-
tance to women who suffer from this condition. The evi-
dence suggests that despite medical therapy7-10
endometriosis is a recurrent disease. Recurrence of
painful symptoms after conservative surgical therapy also
happens,6,11,12 but the rates are lower than for medical
therapies. Furthermore, the prolonged use of medical
therapy is limited by the side effect profile of drugs and
by the fact that the drugs are contraceptive. Therefore,
conservative surgical procedures should theoretically
offer better long-term symptom relief without these side
effects. 
This is potentially of enormous significance to women
who suffer from this condition, and to verify this hypoth-
esis, it was felt that it was important to follow-up the
women who underwent laser laparoscopy in the original
randomized double-blind controlled trial.
MATERIALS AND METHODS
The original study population had been recruited from
women seen in the gynecology outpatient clinic who
had been diagnosed as having endometriosis on previ-
ous laparoscopy or who had pain symptoms suggestive
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of endometriosis. The women were neither pregnant nor
lactating, were aged between 18 and 45 years, and had
not received any treatment for endometriosis during the
previous six months. Unfortunately, some of the women
after they completed the six-month follow-up of the orig-
inal trial took an oral contraceptive pill for contraception
rather than pain relief, and because this will often sup-
press symptoms of endometriosis,13 they had to be
excluded from the long-term follow-up. Between March
1990 and February 1993, 74 women presenting with
pelvic pain and found to have endometriosis in revised
AFS stages 1-111 were recruited. At the time of
laparoscopy, treatment was allocated randomly (comput-
er-generated randomization sequence) to laser surgery or
expectant management.
Laser treatment included vaporization of all visible
endometriotic implants, adhesiolysis, and uterine nerve
transection with the CO2 laser (Sharplan Laser Industries,
Tel Aviv, Israel), and a triple-puncture technique as
described previously12 was used.
Expectant management involved only aspiration of any
serosanguinous fluid from the pouch of Douglas to allow
full inspection of the pelvis. All patients received three
skin incisions and were unaware of the treatment allo-
cated.
Patients were followed up at three and six months by an
independent observer who was also unaware of the treat-
ment allocated. Patients were asked to complete a visual
analogue score at each visit and were asked to give a
subjective assessment of their pain. After the six-month
visit, the randomization code was broken, and if the
patient had received expectant management, a second-
look laparoscopy with laser treatment was offered.
Efficacy was based on changes in the symptoms of dys-
menorrhea, dyspareunia, and pelvic pain reported sub-
jectively, and by visual analogue score. 
In the original trial,1 the randomization code was broken
at the six-month follow-up visit, and 63 women (32 laser
and 31 expectant) had completed the study. Laser
laparoscopy resulted in statistically significant pain relief
in 20 of 32 women (62.5%) compared with expectant
management in 7 of 31 women (22.6%). The patients
were reviewed again at one year (6). Laser laparoscopy
was shown to be an effective treatment for pelvic pain
associated with minimal-to-moderate endometriosis in
90% of patients who responded to the treatment initially.
Of the 74 women who entered the original study, 63 (32
laser and 31 expectant) completed the study to the six-
month follow-up visit. When the randomization code
was broken, 24 patients in the expectant group went on
to have a laser laparoscopy, and seven had no further
surgical treatment. 
Therefore, 56 of the original cohort of patients were
treated by laser laparoscopy, and these patients are the
subjects of this follow-up report. An attempt was made
to contact all 56 women by phone or letter. The patients
were then asked if they had now achieved satisfactory
symptom relief, or if they had received any further med-
ical intervention for their endometriosis. The women’s
responses were recorded by the original independent
observer (research nurse).
RESULTS (Figure 1)
We  were able to contact 38 (67.9%) of the original 56
study participants. The remaining 25 (44.6%) patients
Figure 1. Long-term follow-up results on patients who under-
went laser laparoscopy in the treatment of pelvic pain associat-
ed with minimal-to-moderate endometriosis.were lost to follow-up after three years. The mean
(range) time since operation was 73 months. The mean
age (range) of patients now was 37 (27-50) compared
with 27 (19-41) years at the time of surgery. Painful
symptoms had recurred in 28/38 (73.7%) patients at
some point since their operation. The median (range)
time for recurrence was 19.7 (5-60) months. At the time
of follow-up, satisfactory symptom relief had occurred in
21/38 (55.3%) patients. One woman was menopausal,
seven were leading pain-free lives and had had no need
of further intervention. Two women had had hysterec-
tomies, and endometriosis was found at operation.
Repeat laser laparoscopies to treat new endometriosis
was performed in eight patients. Medical therapy was
being used successfully to control mild symptoms in
three patients. Of the remaining 17/38 (44.7%) patients,
who continued to experience painful symptoms, 11 had
undergone further surgery on one or more occasions.
Eight of these women had eventually had a hysterecto-
my and were noted to have a normal pelvis at operation. 
Repeat laser laparoscopies to treat new endometriosis
was performed in two patients. A further two women
were receiving psychiatric care, with medication for pain,
and one was in an assisted living program. Medical ther-
apy was being used to control severe symptoms in two
patients. One patient complained of pain but was not
being treated for it. 
DISCUSSION
This study is unique because it followed up the largest
single group of untreated patients with continuing pain
symptoms to have the natural history of their disease
documented at second-look laparoscopy. It showed that
if left untreated, painful endometriosis is a dynamic dis-
ease that may remain static (42% of patients), but may
also progress (29% of patients) or diminish (29% of
patients). This has also been demonstrated in captive
baboons assessed by serial laparoscopy.14 Other studies
that have reported the course of endometriosis left
untreated or included a placebo group compared with
medical therapies,3,4,15 support the view that endometrio-
sis is a dynamic disease. Therefore, the majority of
patients are not going to get better if left untreated, and
they require some form of therapy.
The evidence from randomized controlled trials for the
medical and surgical management of endometriosis has
recently been reviewed.16 No trials of medical or surgical
JSLS(2001)5:111-115 113
therapy have been reported following patients beyond
12 months, so it is necessary to examine medical and sur-
gical cohort studies to determine the long-term outcome
following therapy. 
Medical cohort studies extending to five years have
reported a recurrence rate of 50% with danazol and
GnRH analogues.7,8 On the other hand, surgical cohort
studies using life-table analysis have reported a recur-
rence rate of 20% in patients treated by laparoscopic
excision of endometriotic deposits.11 A retrospective five-
year longitudinal follow-up study of patients with all
r-AFS stages of endometriosis showed that up to 70%
of women remained pain free following laser
laparoscopy.12 Unfortunately, this study along with many
other studies published in the late 1980s suffered from all
the defects inherent in any retrospective study especially
when evaluating a highly subjective symptom like pelvic
pain. This finding was supported by a 10-year follow-up
study of patients with endometriomas (r-AFS stage IV
endometriosis ), which showed that up to 74% of women
remained pain free following laser laparoscopy.17 With
these studies in mind, we examined the long-term out-
come of a cohort of patients who underwent laser
laparoscopy in the original trial. 
Because the mean time since operation was 73 months,
it is not surprising that only 38 (67.9%) of the 56 patients
could be contacted. Six (18.8%) other patients were lost
to follow-up. The work patterns of modern society pro-
duce an increasingly mobile population. This makes a
long-term follow-up report such as this difficult, and the
results need to be interpreted with these limitations in
mind. Because the number of patients followed-up was
small in comparison with the original number, it was felt
that it was not worthwhile to analyze the patients in
terms of who initially did or did not respond to therapy
at the six-month stage. The small numbers of patients
involved also precluded analysis of the data in terms of
life-tables. The small numbers also decrease the statisti-
cal power of the study. It is, therefore, difficult to draw
conclusive results. Only a small difference existed in the
proportion of patients who had symptomatic relief fol-
lowing surgery, 21/38 (55.3%) compared with patients
who continue to have painful symptoms 17/38 (44.7%).
This difference is not statistically significant.
The mean age (range) of patients now was 37 (27-50)
compared with 27 (19-41) years at the time of surgery. It
is important to note that the majority of women whoLong-Term Follow-Up of a Controlled Trial of Laser Laparoscopy for Pelvic Pain, Jones KD et al.
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were contacted were not in the menopausal age group,
because this would be expected to relieve women with
endometriosis of their painful symptoms. Only one
woman who was contacted had undergone menopause,
and she was, not surprisingly, pain free. 
At the 12-month follow-up visit, 31 women in the laser
treated group were reviewed, and one was lost to follow-
up. Of the 31 women, 20 were pain free (64.5%). This
long-term follow-up study has shown that painful symp-
toms had recurred in 21/38 (55.3%) patients at some
point since their operation. A wide range of time intervals
existed for recurrence of painful symptoms, which in
some cases extended up to 60 months.
At the time of long-term follow-up, satisfactory symptom
relief was reported in 21/38 (55.3%) patients, and this is
similar to results previously reported from this unit where
symptomatic pain relief of 70% to 74% was achieved.12,6 
However, one woman was menopausal, eight women
had required repeat laser laparoscopies to treat new
endometriosis, and analgesia was being used successful-
ly to control mild symptoms in three patients. Two
women underwent a hysterectomy, and endometriosis
was found at the time of operation. It could be argued
that the original laparoscopic surgery had not been suc-
cessful in these women, but conservative surgery is
aimed at relieving symptoms and not curing the condi-
tion, and it had achieved this as far as these patients were
concerned. The remaining 17/38 (44.7%) patients contin-
ued to experience painful symptoms. 
No attempt was made to separately assess symptoms of
dysmenorrhea, dyspareunia, or other nonmenstrual pain.
We  merely recorded the patient’s interpretation of
whether her symptoms had improved, remained the
same, or deteriorated since the laser treatment. 
Of the 17/38 (44.7%) patients, who continued to experi-
ence painful symptoms, 11 had undergone further sur-
gery on one or more occasions. Eight eventually had a
hysterectomy. Five were found to have a completely nor-
mal pelvis when they underwent hysterectomy, and three
had pelvic adhesions. At histological examination of the
excised tissue, seven had no evidence of endometriosis
or adenomyosis, and one patient had a small single focus
of adenomyosis. Hysterectomy did not relieve the pain of
five of these patients, and the painful pelvic symptoms
were eventually attributed to other causes in these
women, including psychiatric diagnoses. 
A further two women were receiving psychiatric care,
with medication for pain. Whether the pain was the
source of the mental illness or the mental illness influ-
enced the perception of pain is open to speculation. One
woman was in an assisted living program and, therefore,
not on medication specifically for pain relief at that time,
although she still required strong analgesia. A further two
women were regularly using analgesia for severe pain. 
CONCLUSION 
Even though painful symptoms frequently return after
laser laparoscopy, this study suggests that operative
laparoscopy can have long-term benefits for the majority
of women with pelvic pain due to endometriosis, but
because of the small numbers, the study lacks the power
to demonstrate this conclusively. A proportion of patients
who continue to experience painful symptoms, do so
despite a pelvic clearance and no evidence of
endometriosis. 
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